|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500102524 |
|
最近更新日期: Date of Last Refreshed on: |
2025-05-15 16:38:50 |
|
注册时间: Date of Registration: |
2025-05-15 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
妇科肿瘤手术患者静脉血栓栓塞危险因素的回顾性队列研究 |
|
Public title: |
Risk Factors for Venous Thromboembolism in Patients Undergoing Gynecological Tumor Surgery: A Retrospective Cohort Study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
妇科肿瘤手术患者静脉血栓栓塞危险因素的回顾性队列研究 |
|
Scientific title: |
Risk Factors for Venous Thromboembolism in Patients Undergoing Gynecological Tumor Surgery: A Retrospective Cohort Study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
贾春香 |
研究负责人: |
贾春香 |
|
Applicant: |
Chunxiang Jia |
Study leader: |
Chunxiang Jia |
|
申请注册联系人电话: Applicant telephone: |
+86 138 5371 4489 |
研究负责人电话:
Study leader's |
+86 138 5371 4489 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
chunxiangjia@mail.jnmc.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
chunxiangjia@mail.jnmc.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
济宁市任城区古槐路89号 |
研究负责人通讯地址: |
济宁市任城区古槐路89号 |
|
Applicant address: |
No. 89, Guhuai Road, Rencheng District, Jining City |
Study leader's address: |
No. 89, Guhuai Road, Rencheng District, Jining City |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
济宁医学院附属医院 |
||
|
Applicant's institution: |
Affiliated Hospital of Jining Medical University |
||
|
研究负责人所在单位: |
济宁医学院附属医院 |
||
|
Affiliation of the Leader: |
Affiliated Hospital of Jining Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025-04-C010 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
济宁医学院附属医院医学科学研究伦理委员会 |
||
|
Name of the ethic committee: |
Medical Research Ethics Committee of Affiliated Hospital of Jining Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-04-16 00:00:00 | ||
|
伦理委员会联系人: |
齐迪 |
||
|
Contact Name of the ethic committee: |
Di Qi |
||
|
伦理委员会联系地址: |
济宁市任城区古槐路89号 |
||
|
Contact Address of the ethic committee: |
No. 89, Guhuai Road, Rencheng District, Jining City |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 537 290 3496 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
济宁医学院附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Affiliated Hospital of Jining Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
济宁医学院附属医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Affiliated Hospital of Jining Medical University |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
self-raised funds |
||||||||||||||||||||||
|
研究疾病: |
妇科肿瘤 |
||||||||||||||||||||||
|
Target disease: |
Gynecological Tumors |
||||||||||||||||||||||
|
研究疾病代码: |
C51 C52 C53 C54 C56 C57 C58,C76,D25,D27 |
||||||||||||||||||||||
|
Target disease code: |
C51 C52 C53 C54 C56 C57 C58,C76,D25,D27 |
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
1.关联分析:通过建立妇科肿瘤围术期数据库进行回顾性队列研究,明确妇科肿瘤手术患者(包括良性与恶性肿瘤)发生静脉血栓栓塞(VTE)的独立危险因素。 2.风险模型构建:基于危险因素分析,开发适用于妇科肿瘤手术患者的VTE风险预测模型,提升现有评估工具(如Caprini/Padua评分)的预测效能。 3.分层管理验证:探索良性与恶性肿瘤术后VTE危险因素的差异性,为制定血栓预防策略提供循证依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. Correlation Analysis: A retrospective cohort study was performed via constructing a perioperative database of gynecologic oncology to clarify the independent risk factors for VTE in gynecologic oncology surgical patients, including both benign and malignant tumors. 2. Risk Model Construction: Based on the risk factor analysis, a VTE risk prediction model applicable to gynecologic oncology surgical patients was developed to enhance the predictive ability of existing assessment tools, such as the Caprini and Padua scores. 3. Stratified Management Verification: Differences in postoperative VTE risk factors between benign and malignant tumors were explored to provide evidence-based support for developing thromboprophylaxis strategies. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.年龄 >=18岁; 2.患有原发性妇科肿瘤,首次入院接受妇科手术治疗且病理确诊为妇科良性或恶性肿瘤; 3.围术期资料完整,包括围术期常规检查、手术记录、术后记录等。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Age >=18 years; 2. Suffering from primary gynecological tumors, first admission for surgical treatment, and pathologically confirmed benign or malignant gynecological tumor; 3. Complete perioperative data, including routine perioperative examinations, surgical records, and postoperative records. |
||||||||||||||||||||||
|
排除标准: |
1.合并其他严重影响凝血功能的疾病,如血友病、弥散性血管内凝血等; 2.用于分析的主要数据缺失(如关联分析中的暴露和结局指标缺失),无法进行有效分析。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Concurrent with severe coagulation disorders, such as hemophilia, disseminated intravascular coagulation, etc. 2. Missing key data for analysis (for example,absence of exposure and outcome indicators in association analysis), precluding valid analysis. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-05-20 00:00:00至 To 2027-05-20 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-05-20 00:00:00 至 To 2027-05-20 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
支持这项研究的数据集可根据合理请求向通讯作者获取。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The datasets supporting this study are accessible from the corresponding author pending a justified request. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |